Overview

Combination Chemotherapy for the Treatment of Indian Kala-Azar

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The investigators are using a sequential design to combine miltefosine and AmBisome in different doses.
Phase:
Phase 2
Details
Lead Sponsor:
Banaras Hindu University
Treatments:
Amphotericin B
Liposomal amphotericin B
Miltefosine